Temporomandibular Joint Disorders Clinical Trial
Official title:
Is the Temporamandibular Joint and Soft Tissue Mobilization Technique Effective in Individuals Diagnosed With Bening Paroxysmal Positional Vertigo?
Verified date | July 2023 |
Source | Alanya Alaaddin Keykubat University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV).
Status | Completed |
Enrollment | 41 |
Est. completion date | February 20, 2023 |
Est. primary completion date | December 7, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Being diagnosed with positional vertigo, - Being between the ages of 18-65 - Dix Halpike maneuver test (+), - Those who volunteered to participate in the study - Able to read and write. Exclusion Criteria: - Findings of acute or chronic infection at the end of ENT examination, - Considered to have a neurological pathology that causes dizziness, - Head trauma, history of surgical operation, - Having lower extremity pain that prevents standing and weight bearing, - Having a history or symptoms of vestibular system diseases other than BPPV, - Presence of sudden sensory hearing loss and chronic otitis media, - Pregnancy, - The presence of serious cognitive impairment detected by the physician at a level that prevents the tests from being performed, - Not having the mental level to understand and answer the survey questions, - Cervical pathologies that may cause dizziness. |
Country | Name | City | State |
---|---|---|---|
Turkey | Alanyaaku | Antalya | Alanya |
Lead Sponsor | Collaborator |
---|---|
Alanya Alaaddin Keykubat University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dizzness Severity | dizziness severity was determined by Visual Analog Scale (VAS). The patient is asked to evaluate between 0 and 10 points. A score of "0" means no dizziness, a score of "1-4" means mild dizziness, a score of "4-8" means moderate dizziness, and a score of "10" means unbearable dizziness | Baseline - end of the treatment after 4 weeks session | |
Primary | Vertigo Symptom Scale- Shor Form | It is a 15-item scale that evaluates dizziness, feeling of imbalance, accompanying autonomic disorders and anxiety symptoms in the last 1 month.Each question has values between 0-4 points. The scores of all items will be added together and the total score will be between 0-60 points. High scores indicate serious problems. A total score of 12 points or more indicates a symptom of vertigo. It has 8 items related to vertigo and has a score between 0-32 points, it has 7 items that includes autonomic complaints and has a score of 0-28. | Baseline - end of the treatment after 4 weeks session | |
Primary | Beck Anxiety Inventory | It were used for to evaluate of anxiety level because of the vertigo. It consists of 21 questions in total.
0 points: none, point: mild points: intermediate, points: seriously scored. It was classified as mild anxiety symptoms between 8-15 points, moderate anxiety symptoms between 16-25 points, and severe anxiety symptoms between 26-63 points. |
Baseline - end of the treatment after 4 weeks session | |
Primary | Vertigo Dizziness Imbalance Questionnaire (VDI) | The Vertigo-Dizziness-Imbalance Questionnaire is a scale that evaluates the quality of the daily living activities of the problems that patients experience with vertigo and dizzines.Each question has a point value of "4" points if yes, "0" points if no, and sometimes "2" points. In the scoring, 28 points are the limit points for determining physical disability, 36 points for functional and sensory disability. | Baseline - end of the treatment after 4 weeks session | |
Primary | Tinnitus Disability Scale | The Tinnitus Disability Scale (TDS) was used for the presence and level of balance tinnitus due to vertigo.TDS has 25 questions. The scoring of the answers is "4", "0" and "2" respectively. The lowest score that can be obtained from the scale is 0 and the highest score is 100. | Baseline - end of the treatment after 4 weeks session | |
Primary | Balance Asssesment | Balance problems due to vertigo were determined by romberg test, tandem and semitandem tests. Romberg Test:In peripheral vestibular pathologies, the direction of the fall is in that direction. For the Tandem and Semitandem tests,It is asked to try to hold the position for 30 seconds with your open eyes closed. The time it can stand is recorded in seconds | Baseline - end of the treatment after 4 weeks session | |
Primary | The presence of Temporomandibular Joint Disorders | The presence and level of temporomandibular dysfunction was determined by Fonseca's Anamnestic Index (FAI). FAI is a questionnaire consisting of 10 questions and 3 choices. The answers are "yes" (10 points), "sometimes" (5 points), and "no" (0 points). Scoring TMD No signs or symptoms (0-15 points), mild TMD (20-45 points), moderate TMD (50-65 points), and severe TMD (70-100 points) | Baseline - end of the treatment after 4 weeks session | |
Primary | Mouth opening | amount of mouth opening was measured with goniometer before and after treatment. | Baseline - end of the treatment after 4 weeks session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03675659 -
Intra-articular Magnesium Sulfate for Tmj Dysfunction
|
Early Phase 1 | |
Completed |
NCT05740826 -
Correlation Between Cervical Spine Muscle Disorders and the Occurrence of Symptoms of Temporomandibular Joint Dysfunction
|
||
Recruiting |
NCT05006963 -
Tele-Rehabilitation in Patients With Temporomandibular Dysfunction
|
N/A | |
Active, not recruiting |
NCT06103851 -
Effect of Mask Use on Jaw Functionality
|
||
Not yet recruiting |
NCT02908568 -
Stimulation of the Proprioceptive Trigeminocardiac Reflex
|
Phase 2/Phase 3 | |
Completed |
NCT03119324 -
Low Level Laser Therapy in the Treatment of Temporomandibular Joint Disorders (TMJDs) Related Pain
|
N/A | |
Completed |
NCT02247063 -
Motor Cortex as a Research & Therapeutic Target in TMD
|
N/A | |
Recruiting |
NCT06046521 -
Impact of Temporomandibular Joint Dysfunction on Objective and Subjective Vocal Measures
|
||
Completed |
NCT00009594 -
Alternative Medicine Approaches for Women With Temporomandibular Disorders
|
Phase 2 | |
Completed |
NCT00010621 -
Complementary Medicine Approaches to TMD Pain Management
|
Phase 2 | |
Completed |
NCT06055855 -
Comparing Two-Needle vs. Surgery-Guided Arthrocentesis for TMJ Disorders
|
N/A | |
Not yet recruiting |
NCT06259344 -
Pain Science Education Administered in Full or Fractioned Dosage Modes for Temporomandibular Disorders
|
N/A | |
Recruiting |
NCT06035341 -
The Association Between Temporomandibular Disorders and Sacroiliac Joint Dysfunction
|
N/A | |
Completed |
NCT05821985 -
Evaluation of the Effect of Dextrose Prolotherapy Versus Dry Needling Therapy
|
N/A | |
Completed |
NCT06005922 -
The Effectiveness of Temporomandibular Joint Mobilization and Exercise in Individuals With Chronic Neck Pain
|
N/A | |
Completed |
NCT06034756 -
Temporomandibular Joint Problems and Core Stabilization
|
||
Completed |
NCT03576079 -
Effect of Laser Therapy Versus Anterior Re-positioning Splint in the Treatment of Disc Displacement With Reduction
|
N/A | |
Completed |
NCT04557878 -
Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction
|
Phase 2 | |
Completed |
NCT04477122 -
Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome.
|
N/A | |
Completed |
NCT00237042 -
Managing Temporomandibular Disorder (TMD) Symptoms
|
N/A |